Ramírez-Maestre Carmen, Esteve Rosa, Serrano-Ibáñez Elena R, López-Martínez Alicia E
Universidad de Málaga, Facultad de Psicología y Logopedia, Andalucía Tech, Málaga, Spain.
Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Málaga, Spain.
PLoS One. 2025 Oct 22;20(10):e0334918. doi: 10.1371/journal.pone.0334918. eCollection 2025.
Previous research has identified associations between sociodemographic, clinical, and psychological factors and prescription opioid misuse in individuals with chronic noncancer pain (CNCP). A two-study design was used to identify the factors with the most robust association with prescription opioid misuse (Study 1) and to cross-validate these associations in a second sample of people with CNCP to select a reduced number of variables (Study 2). Study 1 included 187 people with CNCP. Point biserial and bivariate correlations, and chi-square analysis showed that the variables significantly associated with opioid misuse were impulsiveness, anxiety sensitivity (AS), pain acceptance, pain catastrophizing, anxiety, depression, posttraumatic stress symptoms (PTSD), and social desirability (medium effect sizes). A family history of alcohol/drug abuse and being between 16 and 45 years of age also reached statistical significance. Study 2 included 179 people with CNCP. The results corroborated the associations found between opioid misuse and impulsiveness, AS, pain acceptance, pain catastrophizing, anxiety, depression, and PTSD. Logistic regression showed that AS, PTSD, and pain acceptance contributed significantly to the unique variance in prescription opioid misuse. Therefore, when prescribing opioids, clinicians should increase the supervision of those people with high AS, PTSD, and low pain acceptance. Evaluating these three variables in people with CNCP who are eligible for opioid therapy could aid in their therapeutic management and help prevent possible iatrogenic effects of opioids. Likewise, this could significantly enhance individual well-being and help mitigate the social problem associated with the misuse of prescription opioids.
先前的研究已经确定了社会人口学、临床和心理因素与慢性非癌性疼痛(CNCP)患者处方阿片类药物滥用之间的关联。采用两项研究设计来确定与处方阿片类药物滥用关联最密切的因素(研究1),并在另一组CNCP患者样本中交叉验证这些关联,以选择数量减少的变量(研究2)。研究1纳入了187名CNCP患者。点二列相关和双变量相关分析以及卡方分析表明,与阿片类药物滥用显著相关的变量有冲动性、焦虑敏感性(AS)、疼痛接纳度、疼痛灾难化、焦虑、抑郁、创伤后应激症状(PTSD)和社会期望性(中等效应量)。酒精/药物滥用家族史以及年龄在16至45岁之间也具有统计学意义。研究2纳入了179名CNCP患者。结果证实了阿片类药物滥用与冲动性、AS、疼痛接纳度、疼痛灾难化、焦虑、抑郁和PTSD之间的关联。逻辑回归分析表明,AS、PTSD和疼痛接纳度对处方阿片类药物滥用的独特方差有显著贡献。因此,在开具阿片类药物处方时,临床医生应加强对高AS、PTSD以及低疼痛接纳度患者的监管。对符合阿片类药物治疗条件的CNCP患者评估这三个变量,有助于他们的治疗管理,并有助于预防阿片类药物可能产生的医源性效应。同样,这可以显著提高个体幸福感,并有助于减轻与处方阿片类药物滥用相关的社会问题。